# BenchSci

Source: https://onco.cc/companies/benchsci/  
OnCo record `benchsci` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

BenchSci develops research software that proposes drug targets and combinations, including early laboratory work in lung cancer.

## Summary

BenchSci's Emet research software combines biomedical information to propose therapeutic hypotheses. A company report describes testing four proposals in human lung squamous cell carcinoma cells and reports that two combinations produced effects exceeding the individual agents. This is company-reported, early laboratory work. It does not demonstrate that the combinations are safe or effective treatments for people.

## Fields

- Kind: Company
- Last checked: 2026-11-06
- HQ: Toronto, ON
- Type: ai-software
- Website: https://www.benchsci.com/

## Notes

- Location is the company's published contact address.

## Sources

- Lung cancer hypothesis-generation research: https://www.benchsci.com/news/introducing-the-hypothesis-generation-agent
- Official location evidence: https://www.benchsci.com/contact
- Elicit AI for Pharma market map: https://elicit.com/ai-for-pharma

## Connected records

- fronts: [AI & Computation](https://onco.cc/fronts/ai-computation/), [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- collections: [Elicit AI for Pharma market map](https://onco.cc/collections/elicit-ai-for-pharma/)

---
JSON: https://onco.cc/api/v1/entities/benchsci.json